Multidrug resistance in Escherichia coli strains isolated from infections in dogs and cats in Poland (2007-2013)

Scientific World Journal

Volumn 2015, Issue , 2015, Pages

  Rzewuska, Magdalena ^a   Czopowicz, Michał ^a   Kizerwetter ͆wida, Magdalena ^a   Chrobak, Dorota ^a   Błaszczak, Borys ^a   Binek, Marian ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFOVECIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ENROFLOXACIN; GENTAMICIN; MARBOFLOXACIN; NEOMYCIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL SKIN DISEASE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CAT DISEASE; CONTROLLED STUDY; DOG DISEASE; EAR INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GASTROINTESTINAL INFECTION; GENITAL TRACT INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; POLAND; PREVALENCE; RESPIRATORY TRACT INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; ZOONOSIS; ANIMAL; CAT; CAT DISEASES; DISK DIFFUSION; DOG; DOG DISEASES; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; VETERINARY;

ANIMALIA; CANIS FAMILIARIS; ESCHERICHIA COLI; FELIDAE;

ANIMALS; ANTI-BACTERIAL AGENTS; CAT DISEASES; CATS; DISK DIFFUSION ANTIMICROBIAL TESTS; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; POLAND;

EID: 84947648731     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2015/408205     Document Type: Article

References (44)

1. L. Guardabassi, S. Schwarz, and D. H. Lloyd, "Pet animals as reservoirs of antimicrobial-resistant bacteria" Journal of Antimicrobial Chemotherapy, vol. 54, no. 2, pp. 321-332, 2004.
2. L. Garcia-Migura, R. S. Hendriksen, L. Fraile, and F. M. Aarestrup, "Antimicrobial resistance of zoonotic and commensal bacteria in Europe: the missing link between consumption and resistance in veterinary medicine" VeterinaryMicrobiology, vol. 170, no. 1-2, pp. 1-9, 2014.
3. R. Bywater, H. Deluyker, E.Deroover et al., "AEuropean survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals" Journal of Antimicrobial Chemotherapy, vol. 54, no. 4, pp. 744-754, 2004.
4. A. Krutkiewicz, A. SaLamaszynska-Guz, M. Rzewuska, D. Klimuszko, and M. Binek, "Resistance to antimicrobial agents of Campylobacter spp. strains isolated from animals in Poland" Polish Journal of Veterinary Sciences, vol. 12, no. 4, pp. 465-472, 2009.
5. L. H. Wieler, C. Ewers, S. Guenther, B. Walther, and A. Lubke-Becker, "Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples" International Journal of Medical Microbiology, vol. 301, no. 8, pp. 635-641, 2011.
6. B. W. Shaheen, D. M. Boothe, O. A. Oyarzabal, and T. Smaha, "Antimicrobial resistance profiles and clonal relatedness of canine and feline Escherichia coli pathogens expressing multidrug resistance in the United States" Journal of Veterinary Internal Medicine, vol. 24, no. 2, pp. 323-330, 2010.
7. P. L. Ho,K.H.Chow, E. L. Lai et al., "Extensive dissemination of CTX-M-producing Escherichia coli withmultidrug resistance to "critically important" antibiotics among food animals in Hong Kong, 2008-10" Journal of Antimicrobial Chemotherapy, vol. 66, no. 4, Article ID dkq539, pp. 765-768, 2011.
8. M. P. V. Cunha, M. G. X. de Oliveira, M. C. V. de Oliveira et al., "Virulence profiles, phylogenetic background, and antibiotic resistance of Escherichia coli isolated from Turkeys with Airsacculitis" The ScientificWorld Journal, vol. 2014,Article ID 289024, 8 pages, 2014.
9. C. Ewers, M. Grobbel, I. Stamm et al., "Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-β-lactamase-producing Escherichia coli among companion animals" Journal of Antimicrobial Chemotherapy, vol. 65, no. 4, Article ID dkq004, pp. 651-660, 2010.
10. J. L. Platell, R. N. Cobbold, J. R. Johnson et al., "Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia" Antimicrobial Agents and Chemotherapy, vol. 55, no. 8, pp. 3782-3787, 2011.
11. L. Beutin, "Escherichia coli as a pathogen in dogs and cats" Veterinary Research, vol. 30, no. 2-3, pp. 285-298, 1999.
12. C. M. Dierikx, E. van Duijkeren, A. H. W. Schoormans et al., "Occurrence and characteristics of extended-spectrum-β-lactamase-and AmpC-producing clinical isolates derived from companion animals and horses" Journal of Antimicrobial Chemotherapy, vol. 67, no. 6, pp. 1368-1374, 2012.
13. H. Huber, C. Zweifel, M. M. Wittenbrink, and R. Stephan, "ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland" Veterinary Microbiology, vol. 162, no. 2-4, pp. 992-996, 2013.
14. S. Kroemer, F. El Garch, D. Galland, J.-L. Petit, F. Woehrle, and H.-J. Boulouis, "Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009)" Comparative Immunology, Microbiology and Infectious Diseases, vol. 37, no. 2, pp. 97-108, 2014.
15. H. E. Sidjabat, K. M. Townsend,M. Lorentzen et al., "Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia" Journal of Medical Microbiology, vol. 55, no. 8, pp. 1125-1134, 2006.
16. L. Osugui, A. F. Pestana de Castro, R. Iovine, K. Irino, and V. M. Carvalho, "Virulence genotypes, antibiotic resistance and the phylogenetic background of extraintestinal pathogenic Escherichia coli isolated from urinary tract infections of dogs and cats in Brazil" Veterinary Microbiology, vol. 171, no. 1-2, pp. 242-247, 2014.
17. CLSI, Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, approved standard, CLSI document VET01-A4, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 4th edition, 2013.
18. CLSI, Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, Second Informational Supplement. CLSI document VET01-S2, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2013.
19. EUCAST, Breakpoint Tables for Interpretation ofMICs and Zone Diameters. Version 3.1, 2013, European Committee on Antimicrobial Susceptibility Testing, 2013, http://www.eucast.org/.
20. CA-SFM, Comite de lAntibiogramme de la Societe Francaise de Microbiologie, Groupe de travail: antibiogramme veterinaire, recommandations, 2010, http://www.sfm-microbiologie.org/UserFiles/file/CASFM/CASFMVET 2010.pdf.
21. B. Seol, K. Matanovic, S. Mekic, and V. Staresina, "In vitro activity of cefovecin, extended-spectrumcephalosporin, against 284 clinical isolates collected from cats and dogs in Croatia" Veterinarski Arhiv, vol. 81, no. 1, pp. 91-97, 2011.
22. A.-P. Magiorakos, A. Srinivasan, R. B. Carey et al., "Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance" Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268-281, 2012.
23. J. H. Zar, Ed., Biostatistical Analysis, PrenticeHall,Upper Saddle River, NJ, USA, 2010.
24. D. G. Altman, D.Machin, T. N. Bryant, and M. J. Gardner, Eds., Statistics with Confidence, BMJ Books, 2000.
25. D. H. Lloyd, "Reservoirs of antimicrobial resistance in pet animals" Clinical Infectious Diseases, vol. 45, supplement 2, pp. S148-S152, 2007.
26. K. Pedersen, H. Jensen, K. Finster, V. F. Jensen, and O. E. Heuer, "Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs" Journal of Antimicrobial Chemotherapy, vol. 60, no. 4, pp. 775-781, 2007.
27. C. P. Murphy, R. J. Reid-Smith, P. Boerlin et al., "Out-patient antimicrobial drug use in dogs and cats for new disease events from community companion animal practices in Ontario" The Canadian Veterinary Journal, vol. 53, no. 3, pp. 291-298, 2012.
28. J. S.Gibson, R.N. Cobbold,M.T.Kyaw-Tanner,P.Heisig, andD. J. Trott, "Fluoroquinolone resistancemechanisms inmultidrugresistant Escherichia coli isolated fromextraintestinal infections in dogs" Veterinary Microbiology, vol. 146, no. 1-2, pp. 161-166, 2010.
29. B.W. Shaheen, R. Nayak, S. L. Foley, and D. M. Boothe, "Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA" Journal of Antimicrobial Chemotherapy, vol. 68, no. 5, Article ID dks514, pp. 1019-1024, 2013.
30. K. R. Ball, J. E. Rubin, M. Chirino-Trejo, and P. M. Dowling, "Antimicrobial resistance and prevalence of canine uropathogens at the Western College of Veterinary Medicine Veterinary Teaching Hospital, 2002-2007" The Canadian Veterinary Journal, vol. 49, no. 10, pp. 985-990, 2008.
31. B. W. Shaheen, R. Nayak, S. L. Foley et al., "Molecular characterization of resistance to extended-spectrumcephalosporins in clinical Escherichia coli isolates from companion animals in the United States" Antimicrobial Agents and Chemotherapy, vol. 55, no. 12, pp. 5666-5675, 2011.
32. R. Belmar-Liberato, A. Gonzalez-Canga, P. Tamame-Martin, and M. Escribano-Salazar, "Amoxicillin and amoxicillin-clavulanic acid resistance in veterinary medicine-the situation in Europe: a review" VeterinarniMedicina, vol. 56, no. 10, pp. 473-485, 2011.
33. A. Philippon, G. Arlet, and G. A. Jacoby, "Plasmid-determined AmpC-type β-lactamases" Antimicrobial Agents and Chemotherapy, vol. 46, no. 1, pp. 1-11, 2002.
34. K. S. Thomson, "Extended-spectrum-β-lactamase, AmpC, and carbapenemase issues" Journal of ClinicalMicrobiology, vol. 48, no. 4, pp. 1019-1025, 2010.
35. R. S. Hendriksen, D. J. Mevius, A. Schroeter et al., "Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002-2004" Acta Veterinaria Scandinavica, vol. 50, article 28, 2008.
36. P.-L. Ho, R. C.Wong, S. W. Lo, K.-H. Chow, S. S.Wong, and T.-L.Que, "Genetic identity of aminoglycoside-resistance genes in Escherichia coli isolates from human and animal sources" Journal ofMedicalMicrobiology, vol. 59,no. 6, pp. 702-707, 2010.
37. N. Soleimani, M.Aganj, L. Ali, L. Shokoohizadeh, and T. Sakinc, "Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital" BMC Research Notes, vol. 7, article 842, 2014.
38. K. Harada, A. Niina, Y. Nakai, Y. Kataoka, and T. Takahashi, "Prevalence of antimicrobial resistance in relation to virulence genes and phylogenetic origins among urogenital Escherichia coli isolates from dogs and cats in Japan" The American Journal of Veterinary Research, vol. 73, no. 3, pp. 409-417, 2012.
39. S. Schwarz, P. Silley, S. Simjee et al., "Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals" Journal of Antimicrobial Chemotherapy, vol. 65, no. 4, pp. 601-604, 2010.
40. N. de Briyne, J. Atkinson, L. Pokludova, S. P. Borriello, and S. Price, "Factors influencing antibiotic prescribing habits and use of sensitivity testing amongst veterinarians in Europe" Veterinary Record, vol. 173, no. 19, article 475, 2013.
41. D. Costa, P. Poeta, Y. Saenz et al., "Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets" Veterinary Microbiology, vol. 127, no. 1-2, pp. 97-105, 2008.
42. J. R. Johnson, M. A. Kuskowski, A. Gajewski, D. F. Sahm, and J. A. Karlowsky, "Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobialsusceptible clinical isolates of Escherichia coli from across the United States, 2000-2001"The Journal of InfectiousDiseases, vol. 190, no. 10, pp. 1739-1744, 2004.
43. S. Wagner, D. L. Gally, and S. A. Argyle, "Multidrug-resistant Escherichia coli from canine urinary tract infections tend to have commensal phylotypes, lower prevalence of virulence determinants and ampC-replicons" Veterinary Microbiology, vol. 169, no. 3-4, pp. 171-178, 2014.
44. C. J. Teale and G. Moulin, "Prudent use guidelines: a review of existing veterinary guidelines" Revue Scientifique et Technique, vol. 31, no. 1, pp. 343-354, 2012.